The Number of Patients with Acute Myocardial Infarction Decreased and Door-to-Balloon Time Delayed in COVID-19.

Tianyi MaYuli HuangWensheng LiJianghua ZhongHui YangYilei ZhouMeijun LiWenhao ZhongYue CaoShijuan Lu Yunzhao Hu

Published in: Cardiology research and practice (2021)

COVID-19 had an impact on the number of AMI patients who were admitted to hospitals and the time of treatment. During the COVID-19 epidemic, the number of AMI patients that were admitted to hospitals per day was decreased, while the percentage of AMI patients that refused therapy in these two hospitals increased, and the D2B time of STEMI patients was also delayed.

Keyphrases

acute myocardial infarction
end stage renal disease
ejection fraction
sars cov
coronavirus disease
newly diagnosed
chronic kidney disease
healthcare
peritoneal dialysis
prognostic factors
heart failure
stem cells
coronary artery disease
mesenchymal stem cells
bone marrow
atrial fibrillation
replacement therapy